Overview

Mobile Health Interventions for Medication Adherence Among PLWH

Status:
Withdrawn
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
Cigarette smoking remains highly prevalent among persons living with HIV (PLWH). Quitting smoking can have important health benefits for this population. However, PLWH have historically had a difficult time quitting smoking. This is likely due, at least in part, to poor medication adherence. Poor adherence to medication is a well-documented issue among PLWH. Research shows that not taking smoking cessation medications as prescribed can limit their treatment effectiveness. Improving adherence to smoking cessation medications will likely increase smoking cessation attempt success. Mobile phone applications and behavioral interventions show promise for improving adherence to smoking cessation medications and cessation outcomes among PLWH. Therefore, this trial will assess 1) whether a mobile phone application is a feasible and acceptable intervention for improving medication adherence; 2) whether use of the mobile phone app improves adherence to varenicline; and 3) smoking cessation outcomes.
Phase:
Phase 4
Details
Lead Sponsor:
Duke University
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Varenicline